0% found this document useful (0 votes)
143 views10 pages

ABA Comments on PTAB Trial Discretion

The document provides comments from the American Bar Association Section of Intellectual Property Law in response to the US Patent and Trademark Office's request for comments on discretion to institute trials before the Patent Trial and Appeal Board. The ABA Section generally supports the PTO promulgating rules with case-specific analyses for applying discretion at institution. It recommends the rules consider factors related to the conduct of both petitioners and patent owners. The ABA Section believes rules should minimize conflicting decisions between courts and the PTAB to preserve integrity in the patent system.
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
143 views10 pages

ABA Comments on PTAB Trial Discretion

The document provides comments from the American Bar Association Section of Intellectual Property Law in response to the US Patent and Trademark Office's request for comments on discretion to institute trials before the Patent Trial and Appeal Board. The ABA Section generally supports the PTO promulgating rules with case-specific analyses for applying discretion at institution. It recommends the rules consider factors related to the conduct of both petitioners and patent owners. The ABA Section believes rules should minimize conflicting decisions between courts and the PTAB to preserve integrity in the patent system.
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 10

November 19, 2020

Mail Stop Patent Board


Director of the U.S. Patent and Trademark Office
P. O. Box 1450
Alexandria, VA 22313-1450
Attention: Vice Chief Administrative Patent Judge Scott C. Weidenfeller

Submitted through the Federal eRulemaking Portal (https://www.regulations.gov)


Docket No. PTO-C-2020-0055

Re: Request for Comments on Discretion to Institute Trials Before the


Patent Trial and Appeal Board

Dear Vice Chief Judge Weidenfeller:

I write on behalf of the American Bar Association Section of Intellectual


Property Law (“Section”) to provide comments in response to the U.S. Patent
and Trademark Office’s (“Office”) Request for Comments on Discretion to
Institute Trials Before the Patent Trial and Appeal Board (“RFC”), 85 Fed. Reg.
66502 (Oct. 20, 2020). The views expressed herein are presented on behalf of
the Section and have not been approved by the House of Delegates or the Board
of Governors of the American Bar Association. Accordingly, they should not be
construed as representing the position of the ABA.

The Section appreciates the Office’s continued efforts to improve America


Invents Act (AIA) trial proceedings before the Patent Trial and Appeal Board
(PTAB or Board), and appreciates the opportunity to provide comments
addressing the Questions identified in the RFC. For the reasons provided below,
the Section generally supports the Office promulgating proposed rules with
case-specific analyses for the Board’s application of discretionary institution
under 35 U.S.C. §§ 314(a) and 324(a). The Section prefers that the Office
engage in the rulemaking process, which includes evaluating public comments
in response to proposed rules, 1 rather than establishing Office binding policy
through precedential or informative decisions.

1
The Section understands the RFC as containing a solicitation for public
comments in response to questions 1-7 as set forth in the RFC. The Section does
not believe that the RFC contains “the terms or substance” of proposed rules in
compliance with 5 U.S.C. § 553(b)(3).

1
The Section has long-standing policy supporting patent operations changes leading to greater
efficiency, consistency, and confidence in the United States patent system. The Section encourages
a strong patent system to incentivize innovators to invent and patent owners to invest resources in
developing their inventions into new products and technologies. Accordingly, the Section supports
the exercise of discretion to minimize conflicting decisions on materially identical issues by a
district court and the PTAB to preserve the integrity of the U.S. patent system.

I. Summary of Comments

The Section recognizes the balance between preventing harassment of patent owners, the need for
inventors, investors and the public to be confident in a US issued patent, and the need to provide an
efficient forum through which a petitioner can challenge the patentability of issued claims as
Congress authorized in the America Invents Act (AIA). In this regard, the Section recommends that
the Office promulgate proposed rules for serial and parallel petitions with case-specific analyses that
take into account the conduct of both petitioners and patent owners. The Section provides
recommended factors below that consider the conduct of both parties to a proceeding. The Section
also provides its view that the Office should reconsider the Fintiv factors in light of the statutory
framework and the realities of ever-changing district court case schedules.

II. Serial Petitions

The Section generally supports the Office promulgating a proposed rule with a case-specific
analysis for the application of discretionary institution with regard to serial or follow-on petitions.
On balance, the Office’s current discretionary institution policies on serial petitions have curtailed
the same or related petitioners from having multiple attacks against a patent. The Office’s current
policies on serial institution focus on the conduct of petitioners based on the nature and timing of
later-filed petitions. However, as discussed in more detail below, the Section believes that the Board
should take into account the conduct of the patent owner. The Office’s current policies on serial
petitions focus predominantly on the conduct of petitioners and may unfairly prejudice later-filing
petitioners who have no meaningful relationship to the original petitioner or who filed later petitions
in response to the timing of the patent owner’s assertion strategy.

1. Should the Office promulgate a rule with a case-specific analysis, such as generally outlined
in General Plastic, Valve I, Valve II and their progeny, for deciding whether to institute a
petition on claims that have previously been challenged in another petition?

Yes, the Section encourages the Office to promulgate a proposed rule with case-specific analysis to
address the issue of serial or follow-on petitions. A rule with a case-specific analysis is preferable
because promulgating a bright-line rule “would only serve to invite gamesmanship.” Shenzhen
Silver Star Intelligent Tech. Co. v. iRobot Corp., IPR2018-00761, Paper 15 at 18-19 (PTAB Sept. 5,
2018) (Saindon, concurring).

The Section generally supports the Office’s guidance set forth in General Plastic, Valve I, Valve II,
and their progeny. However, the Section has concerns that the Office’s current guidance in General
Plastic, Valve I, and Valve II focuses predominantly on the conduct of petitioners, and does not
adequately take into account the conduct of patent owners. The factors that the Office promulgates
in a proposed rule for serial or follow-on petitions should equitably take into account the conduct of
both petitioners and patent owners. The Section also supports the Office carefully examining the
statutory basis for any regulations and gathering and publishing data relevant to any rules.

2
The General Plastic factors focus predominantly on the conduct of petitioners. See Gen. Plastic Co.
v. Canon Kabushiki Kaisha, IPR2016-01357, Paper 19 at 16 (PTAB Sept. 6, 2017) (precedential)
(factors 1-5 focus on the conduct of petitioners, while factors 6 and 7 are neutral to the parties). The
Board has expanded the first General Plastic factor to consider the existence of “any relationship”
between different petitioners. See Valve Corp v. Elec. Scripting Prods., Inc., IPR2019-00062, Paper
11 at 2 (PTAB Apr. 2, 2019) (precedential). This is consistent with the recognition that there is “the
potential for abuse of the review process by repeated attacks on patents.” Gen. Plastic, IPR2016-
01357, Paper 19 at 16-17. Through case-specific application of the General Plastic factors, serial
filings by the same or related petitioners have been minimized. Any promulgated rule should
continue to provide this effect of preventing the same or related petitioners from having multiple
bites at the apple, particularly when the same or related petitions use earlier filings of the patent
owner or Board decisions in pursuing modified grounds of challenge.2

The Section also encourages the Office to promulgate a proposed rule that expressly considers the
conduct of patent owners in related proceedings involving the challenged patent. Patent owners may
serially assert their patents against multiple defendants over the course of multiple years. See, e.g.,
NetApp Inc. v. Realtime Data LLC, IPR2017-01195, Paper 9 at 6-8 (PTAB Oct. 12, 2017)
(identifying proceedings asserting the challenged patent against different parties over time);
Microsoft Corp. v. IPA Tech. Inc., IPR2019-00838, Paper 9 at 3 (PTAB Nov. 7, 2019) (same). By
considering such behavior when evaluating serial petitions, the Office can minimize incentives for
patent owners to take advantage of the Board’s general restrictions against subsequent petitions that
unfairly disadvantage later petitioners that had no involvement in an earlier IPR.

For example, General Plastic factor 3 considers whether a preliminary response has been filed or a
decision to institute has been issued in earlier proceedings. See Gen. Plastic, IPR2016-01357, Paper
19 at 9, 11. This factor exists to prevent similarly situated petitioners from using prior filings as a
road map to improve their subsequent petitions. Id. But many later petitions are not the result of a
petitioner’s delay to gain a strategic advantage by reviewing earlier-filed papers. Some petitioners
simply receive notice of an infringement complaint late in a patent owner’s assertion campaign. Yet
these later-sued petitioners sometimes cannot overcome factor 3 if an earlier petition has been filed.
In these situations, the General Plastic factors unfairly prejudice later-sued petitioners. Congress did
not intend inter partes review to be available only to the first-sued petitioner, or the petitioner who
filed the first petition when the patent owner sues different, unrelated defendants over a period of
time.

These subsequent petitioners should not be penalized, particularly if their unpatentability challenges
differ materially from those previously presented. Considering the timing of the patent owner’s
assertion pattern, along with other conduct, would prevent the type of gamesmanship of the General
Plastic factors that effectively prevents later-sued defendants from having their say before the
Board. This would also allow panels to discourage other forms of gamesmanship such as the late

2
The Section, however, supports Board decisions that have refused to rely on participation in
joint defense groups as a basis to deny petitions. See, e.g., Microsoft Corp. v. Koninklijke Philips
N.V., IPR2018-00023, Paper 7 at 12-13 (PTAB Apr. 11, 2018) (Board declined to deny
institution of a later-filed petition filed by a different petitioner that shared a common interest
with earlier-filing petitioners in the patent-at-issue). Such participation should not be
discouraged as it promotes efficiency in litigation.

3
identification of asserted claims in parallel proceedings. See, e.g., Facebook, Inc. v. Windy City
Innovations, LLC, IPR2017-00709, Paper 11 at 2-4 (PTAB Aug. 1, 2017) (describing patent
owner’s identification of asserted claims after the one-year statutory bar); Microsoft Corp. v. IPA
Tech. Inc., IPR2019-00812, Paper 12 at 9-15 (PTAB Oct. 17, 2019) (same).

When promulgating a proposed rule with a case-specific analysis for serial or follow-on petitions,
the Office should also consider the merits of the patentability challenges presented in later-filed
petitions. Notably, the merits of challenges presented in a later-filed petition is absent from the
General Plastic factors.

Therefore, the Section recommends that the Office promulgate a proposed rule with a case-specific
analysis that takes into account the conduct of both petitioners and patent owners. In addition to the
seven General Plastic factors, 3 the Section recommends that the Office also include the following
two additional factors:

8. whether the patent owner’s conduct unfairly impacted the timing of a later petition
filed against the patent; and
9. if a later-filed petition is filed by a different petitioner, whether the later-filed petition
presents materially different grounds than the earlier petition, and whether the merits of the later-
filed petition warrant institution of review.

Proposed new factor 8 expands on General Plastic factor 5, which is limited to “the same claims of
the same patent.” Gen. Plastic, IPR2016-01357, Paper 19 at 16 (“5. whether the petitioner provides
adequate explanation for the time elapsed between the filings of multiple petitions directed to the
same claims of the same patent.”). There may be circumstances in which a later petitioner might
challenge a different set of claims than an earlier petition, even if there is some overlap in the claims
challenged, possibly due to a subsequent assertion of the patent against a different defendant.

2. Alternatively, in deciding whether to institute a petition, should the Office (a) altogether
disregard whether the claims have previously been challenged in another petition, or (b)
altogether decline to institute if the claims have previously been challenged in another
petition?

See response to question 1. The Section believes the Board should promulgate a proposed rule with
a case-specific analysis that considers the conduct of both petitioners and patent owners to equitably
balance the interests of all parties before the PTAB.

III. Parallel Petitions

The Section generally supports the Office promulgating a proposed rule with a case-specific
analysis for the application of discretionary institution when parallel petitions are filed. However, as
discussed in more detail below, the Section believes that the Office’s guidance has been unduly
restrictive on balance. The Office’s current policies on parallel petitions focus predominantly on the
conduct of petitioners. The Office should also take into account the conduct of patent owners in its
analysis. Further, to avoid discretionary denials based on developments in other tribunals, the Office

3
See General Plastic, IPR2016-01357, Paper 19 at 16.

4
should recognize that petitioners may feel compelled to file parallel petitions before there is clarity
on which claims are at issue in parallel litigation.

3. Should the Office promulgate a rule with a case-specific analysis, such as generally outlined
in the Consolidated Trial Practice Guide, for deciding whether to institute more than one
petition filed at or about the same time on the same patent?

Yes, the Section supports the Office promulgating a proposed rule with a case-specific analysis to
guide Board panels on exercising discretion to institute or deny parallel petitions that are filed by the
same petitioner(s) at or near the same time. The Section supports establishing policies by rule rather
than by decisions that are designated precedential without public input. The Section also supports
the Office carefully examining the statutory basis for any regulations and gathering and publishing
data relevant to any rules.

The Section appreciates the Office’s balancing of a petitioner’s desire to be heard with not
“plac[ing] a substantial and unnecessary burden on the Board and the patent owner.” See
Consolidated Trial Practice Guide (CTPG), at 59. But the Office’s current policies have effectively
created a rebuttable presumption that only one petition by the same petitioner may be instituted. On
balance, the Office should not create a presumption in favor of instituting only one petition per
patent, but rather address parallel petitions on a case-by-case basis.

The Office identifies two examples where multiple petitions by the same petitioner may be
appropriate: (1) when the patent owner has asserted a large number of claims in litigation, or (2)
when there is a dispute about a priority date requiring arguments under multiple prior art references.
Id. Situation (1) above assumes that a petitioner has been informed of the claims that are asserted in
litigation before the petitioner files its petition(s). It is not unusual for patent owners to add claims to
a litigation after the one-year bar period has passed. See, e.g., Facebook Inc. v. Windy City
Innovations, LLC, IPR2017-00659 and IPR2017-00709 (petitions filed to challenge claims added to
the district court litigation after the one-year time-bar had passed); see also Microsoft Corp. v. IPA
Techs. Inc., IPR2019-00810 to -00814 (Board instituted five petitions challenging all 89 claims of
the patent because the patent owner did not identify the asserted claims until after the one-year bar
had passed). Due to the Board’s increasing use of discretionary denials when patent owners sue in
fast-moving forums, a petitioner may believe it is compelled to file one or more petitions before the
patent owner informs the petitioner which claims it is asserting. A district court’s rules may also
allow a patent owner to add additional claims in amended contentions in the future. Therefore,
rather than focus on the number of claims that a patent owner has asserted in the litigation, the
Board should instead consider the merits of a petitioner’s challenges based on the number of claims
in the patent.

The Office should address this situation in rulemaking now that petitioners may no longer pursue
same-party joinder to challenge additional claims that are asserted after the one-year time-bar of 35
U.S.C. § 315(b) has passed. See Facebook, Inc. v. Windy City Innovations, LLC, 973 F.3d 1321,
1333 (Fed. Cir. 2020) (holding that same-party and issue joinder is not permissible under 35 U.S.C.
§ 315(c)). Thus, the Office should provide petitioners greater flexibility in addressing claims in
separate petitions to account for this uncertainty created by patent owners.

Further, due to the Board’s increasing use of discretionary denials when patent owners sue in fast-
moving forums, a petitioner may believe it is compelled to file one or more petitions before a patent
owner advises (i) how the petitioner’s products or processes are alleged to infringe the asserted

5
claims, or (ii) how the patent owner is construing the asserted claims. For example, a petitioner may
file parallel petitions within 4-6 months of service of a complaint, before the patent owner discloses
which claims it intends to assert, how it alleges the petitioner’s products or processes infringe the
asserted claims, or how it is construing the claims. Due to this uncertainty, a petitioner may need to
pursue multiple petitions with different grounds based on different claim constructions that the
patent owner may pursue in parallel litigation.

The Section believes that efficiencies are gained in the dispute between the parties when a petitioner
may pursue alternative grounds based on different claim constructions that the patent owner may
pursue in parallel litigation. A district court may be more inclined to stay parallel litigation if the
Board institutes multiple challenges against the asserted claims. When determining whether to
exercise its discretion to institute or deny parallel petitions presenting alternative grounds of
unpatentability, the Board should take into account, in addition to the merits of a petitioner’s
challenges, whether the patent owner had disclosed, at the time the petitioner filed its parallel
petitions, the claims of the patent being asserted and the total number of claims, the products or
processes of the petitioner that are accused of infringement, and the claim construction positions of
the patent owner.

On balance, the Section believes that the Board’s denial of meritorious challenges to claims on
procedural grounds may unnecessarily increase costs for the parties and undermine the purposes of
the AIA to provide an expert administrative review of patents. Procedurally denying meritorious
petitions can have the disadvantageous effect of increasing costs for the parties by shifting validity
disputes to other more costly forums, such as district courts or the International Trade Commission
(ITC). A petitioner is not estopped from raising validity challenges in district court or the ITC when
the Board denied institution for those challenges. See Shaw Indus. Grp, Inc. v. Automated Creel
Sys., Inc., 817 F.3d 1293, 1300 (Fed. Cir. 2016). To be clear, the Section is not advocating that the
Board permit a limitless number of challenges. Rather, the Board should promulgate a proposed rule
with a case-specific analysis accounting for the merits of the challenges in parallel petitions and the
conduct of both petitioners and patent owners. The Board’s analysis should consider at least the
following non-exhaustive factors:

(a) the merits of the challenges presented in parallel petitions;


(b) whether the challenges presented in parallel petitions are materially different;
(c) whether the patent owner has asserted a large number of claims in litigation;
(d) the number of claims in the challenged patent and the degree of specificity, at the time
parallel petitions were filed, about the claims in the patent that could be asserted against the
petitioner;
(e) the degree of specificity, at the time parallel petitions were filed, about how the patent
owner is construing and asserting the challenged claims;
(f) if different challenges are pursued in parallel petitions based on different claim
construction positions, the reasonableness of the alternative claim constructions advanced by the
petitioner; and
(g) whether there is a dispute about a priority date requiring arguments under multiple
prior art references.

The Section believes that promulgating a proposed rule with the above factors for consideration of
parallel petitions properly balances fairness, timing and efficiency concerns from parallel petitions,
and consideration of meritorious challenges to patent claims asserted in parallel litigation.

6
4. Alternatively, in deciding whether to institute more than one petition filed at or about the
same time on the same patent, should the Office (a) altogether disregard the number of
petitions filed, or (b) altogether decline to institute on more than one petition?

See response to question 3.

IV. Proceedings in Other Tribunals

5. Should the Office promulgate a rule with a case-specific analysis, such as generally outlined
in Fintiv and its progeny, for deciding whether to institute a petition on a patent that is or has
been subject to other proceedings in a U.S. district court or the ITC?

If the Office continues to maintain the position that it has the authority to deny a petition based on
the status of parallel litigation, the Section generally supports the Office promulgating a proposed
rule with a case-specific analysis for deciding whether to institute a petition on a patent that is
involved in parallel litigation in a U.S. district court or the ITC. Consistent with the comments
above, the Section prefers that the Office engage in rulemaking to establish binding policy rather
than creating binding policy through precedential decisions or other guidance. The Section also
supports the Office carefully examining the statutory basis for any regulations and gathering and
publishing data relevant to any rules.

Based on a review of the statistics regarding factors such as trial dates, the Fintiv factors appear to
be based on incorrect assumptions regarding the realities of unpredictable litigation. For example,
the first Fintiv factor has Administrative Patent Judges (APJs) analyzing the likelihood of a
particular court issuing a stay, something that can be hard to predict (at best). In fact, in the vast
majority of cases the district court does not even decide whether to stay the case until after the initial
determination by the Office in the IPR proceeding. The second factor asks the APJs to compare
whether a district court is scheduled to go to trial before the prospective date on which the Board
would issue a final written decision. See Fintiv, IPR2020-00019, Paper 11 at 9 (“If the court’s trial
date is earlier than the projected statutory deadline, the Board generally has weighed this fact in
favor exercising authority to deny institution under NHK.”). But this reasoning ignores the fact that
scheduled district court trial dates often move, including when the scheduled dates of district courts
are used by the Board as one of the bases to deny institution. For example, in NHK, a Board panel
denied institution in part due to the “advanced state of the district court proceedings.” NHK,
IPR2018-00752, Paper 8 at 20. There, the panel specifically focused on the fact that a district court
trial was set for approximately six months before the statutory deadline for issuing a final written
decision if the Board instituted review. Id. at 19–20. But shortly thereafter, the court in the parallel
district court case moved the trial date back six months. See Intri-Plex Techs. v. NHK Int’l Corp.,
No. 3:17-cv-01097, ECF Nos. 173, 175 (N.D. Cal.). At least one subsequent Board panel pointed to
this fact—which undermined the basis for denying institution in NHK—as “illustrating the
uncertainty associated with litigation schedules.” See Mylan Pharma. Inc. v. Sanofi-Aventis
Deutschland GmbH, IPR2018-01670, Paper 19 at 10 n.3 (PTAB Apr. 3, 2019). Commentators have
reported that scheduled district court trial dates are often moved, on average, by three to seven
months, including in the District of Delaware and the Western District of Texas, which are popular

7
forums for bringing patent infringement complaints. 4 Under the Fintiv factors, APJs are not even
asked to consider the likelihood of a trial date moving.

The Office should not base discretionary denials on scheduled trial dates that are often moved for a
variety of reasons. One petitioner was able to successfully request rehearing of a discretionary
denial after the district court moved the trial date, but that was only because the trial date was
moved within the thirty-day period during which the petitioner could request rehearing. See Sand
Revolution II, LLC v. Continental Intermodal Grp.—Trucking LLC, IPR2020-01393, Paper 24
(PTAB June 16, 2020) (informative) (panel granted institution on rehearing of discretionary denial
based on finding that uncertainty over district court’s trial date weighed against discretionary
denial).

The Fintiv factors may also lead to disparate results based on where a patent owner chooses to file
suit. To date, the application of the Fintiv factors has led to a starkly higher rate of discretionary
denials when the patent owner files its infringement complaint in faster-moving district courts
having accelerated trial dates. U.S. District Courts for the Western District of Texas and the Eastern
District of Texas provide faster times to trial due to their accelerated trial schedules, as compared to
other U.S. district courts. 5 These accelerated trial schedules have led to a disproportionate number
of discretionary denials in comparison to IPRs involving patents that are being asserted in other U.S.
district courts. One commentator recently found that 56% of petitions were discretionarily denied
by the Board under Fintiv when the parallel district court case was brought in either the Western
District of Texas or the Eastern District of Texas. 6 In comparison, only 3% of petitions were
discretionarily denied under Fintiv in all other forums. 7 This stark disparity in outcomes can
effectively prevent a defendant from pursuing validity defenses before the PTAB based on the
forum that the patent owner chooses.

If the Office continues to use any of the Fintiv factors, the Section also recommends that the Office
recast Fintiv factor 4 to limit its applicability and avoid variation in application by Board panels. As
noted in the explanation of Fintiv factor 4, the Board in NHK was presented with “substantially
identical prior art arguments that were at issue in the district court.” Fintiv, IPR2020-00019, Paper
11 at 12. Based on this fact, the Board explained that “concerns of inefficiency and the possibility of
conflicting decisions were particularly strong.” Id. Some Board panels have indicated that the
potential for “inconsistent results” weighs in favor of discretionary denial under Fintiv. See, e.g.,
Intel Corp. v. VLSI Tech. LLC, IPR2020-00583, Paper 22 at 11 (PTAB Oct. 5, 2020) (“[I]nstituting

4
See Scott McKeown, “District Court Trial Dates Tend to Slip After PTAB Discretionary
Denials,” available at https://www.patentspostgrant.com/district-court-trial-dates-tend-to-slip-
after-ptab-discretionary-denials/.
5
For example, Judge Albright’s default scheduling order for patent cases in the Western District
of Texas provides that trial should occur approximately 18 months from the initial case
management conference. See https://www.txwd.uscourts.gov/wp-
content/uploads/Standing%20Orders/Waco/Albright/Sample%20Order%20Governing%20Proce
edings%20-%20Patent%20Cases%20092220.pdf. According to statistics from Docket
Navigator, the median time to trial in the Eastern District of Texas for a patent case filed since
January 1, 2018 is 24.1 months.
6
See Brenton Babcock et al., “A Proposed Alternative to PTAB Discretionary Denial Factors,”
available at https://www.law360.com/articles/1315934/a-proposed-alternative-to-ptab-
discretionary-denial-factors?
7
Id.

8
an inter partes review would likely duplicate the district court’s efforts and could lead to
inconsistent results, undercutting the efficiency and integrity of the patent system.”). Some Board
panels have held that simply having two references in common with the petitioner/defendant’s
preliminary invalidity contentions is sufficient to create the potential for “inconsistent results.” See,
e.g., U.S. Venture, Inc. v. Sunoco Partners Marketing & Terminals L.P., IPR2020-00728, Paper 10
at 14 (PTAB Oct. 1, 2020) (in denying institution under Fintiv, the panel explained that because two
references were included in the IPR and the petitioner/defendant’s preliminary invalidity
contentions, “instituting an inter partes review would likely duplicate the district court’s efforts, as
well as create the potential for inconsistent results, both of which undercut the efficiency and
integrity of the patent system.”).

If the Office continues to use this factor, the Section believes that, in general, Fintiv factor 4 should
weigh in favor of discretionary denial only when a petitioner/defendant is pursuing the same
references on the same grounds in district court that are asserted in the petitioner/defendant’s
grounds raised in an IPR petition. If the petitioner/defendant stipulates not to pursue grounds in the
district court or ITC relying on those same grounds if the IPR is instituted, then there cannot be
inconsistent results between the IPR and the other proceeding. See Sand Revolution, IPR2019-
01393, Paper 24 at 12 (petitioner’s stipulation to not pursue the same grounds in district court
mitigates “concerns of potentially conflicting decisions.”); see also NanoCellect Biomedical, Inc. v.
Cytonome/ST, LLC, IPR2020-00551, Paper 19 at 23 (PTAB Aug. 27, 2020) (petitioner’s stipulation
resulted in “no overlap” between the IPR and district court proceeding); Apple Inc. v. SEVEN
Networks, LLC, IPR2020-00285, Paper 10 at 22 (PTAB July 28, 2020) (petitioner’s stipulation to
not pursue the same grounds in district court mitigates “concerns of duplicative efforts between the
district court and the Board, as well as potentially conflicting decisions.”).

If the Office continues to maintain that it has the proper authority, the Section therefore
recommends that the Office promulgate a proposed rule with a case-specific analysis for deciding
whether to institute a petition on a patent that is involved in parallel litigation in a U.S. district court
or the ITC. However, the Section does not support the Office promulgating a rule consistent with all
factors of Fintiv, for the reasons presented above. Further, the Section’s comments above in
response to question 5 should also be viewed in conjunction with the Section’s comments below in
response to question 6.

6. Alternatively, in deciding whether to institute a petition on a patent that is or has been


subject to other proceedings in district court or the ITC, should the Office (a) altogether
disregard such other proceedings, or (b) altogether decline to institute if the patent that is or
has been subject to such other proceedings, unless the district court or the ITC has indicated
that it will stay the action?

Given the statutory framework established by Congress, the Section encourages the Office to deny
IPR institution based on parallel district court or ITC proceedings, in general, only when the
petitioner files its IPR petition more than one year after the patent owner serves the petitioner with a
district court complaint asserting infringement of the patent at issue. In a section entitled “Relation
to Other Proceedings or Actions,” the AIA expressly addresses how to proceed when there is a
competing action. The Office will deny any IPR petition filed more than one year after the service
of a district court infringement complaint. 35 U.S.C. § 315(b). Congress declined to bar institution
based on any other time limitation with respect to other actions, including any requirement that the
final written decision be issued prior to any district court jury trial. For example, the proposed bill
originally allowed only six months after service of a district court complaint to file an IPR. See 157

9
Cong. Rec. S5429 (daily ed. Sept. 8, 2011). Congress, however, was persuaded that this did not
allow enough time for petitioners:

High-technology companies, in particular, have noted that they are often sued by
defendants asserting multiple patents with large numbers of vague claims, making it
difficult to determine in the first few months of the litigation which claims will be
relevant and how those claims are alleged to read on the defendant’s products.
Current law imposes no deadline on seeking inter partes reexamination. And in light
of the present bill’s enhanced estoppels, it is important that the section 315(b)
deadline afford defendants a reasonable opportunity to identify and understand the
patent claims that are relevant to the litigation. It is thus appropriate to extend the
section 315(b) deadline to one year.

Id. Additional protections were also provided to protect patent holders with respect to parallel
proceedings. If an entity files a civil action seeking to invalidate a patent, then it may not later file an
IPR on that patent. 35 U.S.C. § 315(a)(1). However, Congress expressly allowed IPRs to be filed by
district court defendants who raise invalidity counterclaims when sued for infringement. 35 U.S.C. §
315(a)(3).

NHK, Fintiv and other similar decisions refusing to institute IPRs because a district court or ITC
trial has been set before the estimated date for the PTAB’s final written decision upset this balance
and goes beyond the letter and intent of the pertinent provisions of the AIA. Congress already
considered the views of those advocating that an IPR should always be denied when there is parallel
district court litigation and the views of those advocating that an IPR should never be denied in
favor of district court litigation. Congress struck a careful balance that should not now be upset.

V. Other Considerations

7. Whether or not the Office promulgates rules on these issues, are there any other
modifications the Office should make in its approach to serial and parallel AIA petitions,
proceedings in other tribunals, or other use of discretion in deciding whether to institute an
AIA trial?

The Section has provided recommended modifications to the Office’s current policies in response to
questions 1, 3, 5, and 6 above.

****
The Section thanks the Office for the opportunity to submit these comments. We would be pleased
to further discuss these comments with the Office and others as appropriate. The Section encourages
the Office to continue to make strides toward patent system policies enhancing efficiency,
predictability and confidence in the U.S. patent system.

Sincerely,

June M. Besek Chair


ABA Section of Intellectual Property Law

10

You might also like